Peripheral and tumor-infiltrating immune cells are correlated with patient outcomes in ovarian cancer.

Weiwei Zhang Yawen LingZhidong LiXing-Chen PengYazhou Ren

Published in: Cancer medicine (2023)

These results suggest that both peripheral blood markers and TICs can be used as prognostic predictors in patients with OC, and CXCL9, CD79A, MS4A1, and MZB1 may be potential therapeutic targets for OC immunotherapy.

Keyphrases

peripheral blood
mass spectrometry
multiple sclerosis
ms ms
chemotherapy induced